患者管理ソリューション市場：コンポーネント、展開モード、エンドユーザー、アプリケーション別-2025-2030年の世界予測

患者管理ソリューション市場は、2023年に164億2,000万米ドルと評価され、2024年には186億6,000万米ドルに達すると予測され、CAGR 13.73％で成長し、2030年には404億2,000万米ドルに達すると予測されています。

患者参加型ソリューションには、患者自身がヘルスケア・プロセスに積極的に参加し、転帰と満足度を向上させるように設計されたツールやシステムが幅広く含まれます。これらのソリューションは、患者の関与が治療の成功やリソースの最適化に直結する、価値ベースのケアに焦点を当てた進化するヘルスケア状況のために必要です。アプリケーションは、電子カルテ（EHR）ポータル、モバイルヘルスアプリ、患者教育ツールから遠隔モニタリングシステムや遠隔医療サービスまで多岐にわたる。最終使用領域は、主に病院、診療所、在宅ケア設定で、技術の進歩とインターネットの普及により新興市場での採用が増加しています。

市場の洞察によると、患者エンゲージメント・ソリューションの成長は、主に人工知能などの技術的進歩、ヘルスケア支出の増加、患者中心のケア重視の高まりが原動力となっています。また、慢性疾患の増加により、継続的な患者との対話とモニタリングが必要となり、需要が活性化しています。モバイルプラットフォーム向けのソリューションの調整や、リアルタイムの健康追跡のためのウェアラブル技術の統合には機会が豊富にあり、これらの領域に投資する企業に大きな成長軌道を提供しています。このような機会を生かすために、企業はテクノロジー企業やヘルスケアプロバイダーとのコラボレーションを促進し、相互運用可能でユーザーフレンドリーなソリューションを開発する必要があります。

しかし、同市場は、導入コストの高さ、プライバシーへの懸念、従来の慣行の変化によるヘルスケア従事者の抵抗といった限界に直面しています。また、データセキュリティの問題や厳しい規制基準への対応といった課題もあり、迅速な市場浸透の妨げとなっています。革新的な分野としては、予測的洞察のためのデータ分析機能の強化や、患者の関与を高めるための直感的なユーザーインターフェースの開発などが挙げられます。調査は、異種ヘルスケアシステム間の相互運用性の向上に重点を置くべきです。市場の競争は激しく、急速に進化しています。そのため、持続的な成長とリーダーシップを発揮するためには、技術動向や規制の変化に機敏に対応し、継続的に適応していくことが重要となります。

市場力学：急速に進化する患者管理ソリューション市場の主要市場インサイトを公開

患者管理ソリューション市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • モバイルヘルスアプリの採用増加
  • 患者中心の医療を推進する政府の取り組み
  • ヘルスケア情報技術への投資
• 市場抑制要因
  • 患者データのセキュリティ脅威
• 市場機会
  • ウェアラブル・ヘルス技術の発展
  • 患者情報管理と識別の継続的発展
  • ヘルスケアにおけるクラウドベースモデルの受け入れ拡大
• 市場の課題
  • 高いソリューション展開コスト

ポーターの5つの力：患者管理ソリューション市場をナビゲートする戦略ツール

ポーターの5つの力」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：患者管理ソリューション市場における外部からの影響の把握

外部マクロ環境要因は、患者管理ソリューション市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析患者管理ソリューション市場における競合情勢の把握

患者管理ソリューション市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス患者管理ソリューション市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、患者管理ソリューション市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨患者管理ソリューション市場における成功への道筋を描く

患者管理ソリューション市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • モバイルヘルスアプリの普及増加
    • 患者中心のケアを推進する政府の取り組み
    • ヘルスケア情報技術への投資
  • 抑制要因
    • 患者のデータセキュリティの脅威
  • 機会
    • ウェアラブルヘルステクノロジーの開発の進展
    • 患者情報の管理と識別に関する継続的な開発
    • ヘルスケアにおけるクラウドベースモデルの普及拡大
  • 課題
    • ソリューション導入コストが高い
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 患者管理ソリューション市場：コンポーネント別

• ハードウェア
• サービス
• ソフトウェア

第7章 患者管理ソリューション市場：展開モード別

• クラウド上
• オンプレミス

第8章 患者管理ソリューション市場：エンドユーザー別

• ヘルスケア支払者
• 病院と医療機関
• 製薬会社

第9章 患者管理ソリューション市場：用途別

• 財務健全性管理
• 健康管理
• 在宅健康管理
• 社会および行動管理

第10章 南北アメリカの患者管理ソリューション市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の患者管理ソリューション市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの患者管理ソリューション市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AdvancedMD, Inc.
• Allscripts Healthcare, LLC
• Athenahealth Inc.
• Cerner Corporation
• Cognizant Corporation
• CureMD Healthcare Corporation
• Epic Systems Corporation
• Getwellnetwork, Inc.
• Internatonal Business Machines Corporation
• Iqvia Inc.
• Kareo Inc.
• Lincor Solutions Ltd.
• Mckesson Corporation
• Orion Health Inc.
• Vivify Health Inc.

LIST OF FIGURES

• FIGURE 1. PATIENT ENGAGEMENT SOLUTION MARKET RESEARCH PROCESS
• FIGURE 2. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. PATIENT ENGAGEMENT SOLUTION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. PATIENT ENGAGEMENT SOLUTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PATIENT ENGAGEMENT SOLUTION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PATIENT ENGAGEMENT SOLUTION MARKET DYNAMICS
• TABLE 7. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON- CLOUD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOSPITALS & PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY FINANCIAL HEALTH MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HEALTH MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOME HEALTH MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOCIAL & BEHAVIOURAL MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 37. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 59. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 63. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 132. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. POLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 148. POLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. POLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. QATAR PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 152. QATAR PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. QATAR PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. PATIENT ENGAGEMENT SOLUTION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 192. PATIENT ENGAGEMENT SOLUTION MARKET, FPNV POSITIONING MATRIX, 2023

The Patient Engagement Solution Market was valued at USD 16.42 billion in 2023, expected to reach USD 18.66 billion in 2024, and is projected to grow at a CAGR of 13.73%, to USD 40.42 billion by 2030.

Patient engagement solutions encompass a broad array of tools and systems designed to actively involve patients in their own healthcare processes, thus improving outcomes and satisfaction levels. These solutions are necessary due to an evolving healthcare landscape focused on value-based care, where patient involvement directly correlates with treatment success and resource optimization. Applications span from electronic health records (EHR) portals, mobile health apps, and patient education tools to remote monitoring systems and telehealth services. End-use domains primarily include hospitals, clinics, and home care settings, with an increasing adoption in emerging markets due to technological advances and internet penetration.

Market insights reveal that the growth of patient engagement solutions is driven mainly by technological advancements such as artificial intelligence, increased healthcare expenditure, and a rising emphasis on patient-centric care. The growing prevalence of chronic diseases also necessitates continuous patient interaction and monitoring, thus invigorating demand. Opportunities abound in tailoring solutions for mobile platforms and integrating wearable technology for real-time health tracking, offering a significant growth trajectory for companies investing in these domains. To capitalize on these opportunities, businesses should foster collaborations with technology firms and healthcare providers to develop interoperable and user-friendly solutions.

However, the market faces limitations such as high implementation costs, privacy concerns, and resistance from the healthcare workforce due to changes in traditional practices. Additional challenges include data security issues and compliance with stringent regulatory standards, which can impede swift market penetration. Innovation areas include enhancing data analytics capabilities for predictive insights and the development of intuitive user interfaces to foster greater patient engagement. Research should focus on improving interoperability between disparate healthcare systems. The market's nature is competitive and rapidly evolving; therefore, agility and continuous adaptation to technology trends and regulatory changes will be crucial for sustained growth and leadership.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Patient Engagement Solution Market

The Patient Engagement Solution Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising adoption of mobile health apps
  • Government initiatives to promote the patient-centered care
  • Investments in the healthcare information technology
• Market Restraints
  • Patient's data security threats
• Market Opportunities
  • Growing development of wearable health technology
  • On-going developments in patient information management and identification
  • Rising acceptance of cloud-based models in healthcare
• Market Challenges
  • High solution deployment cost

Porter's Five Forces: A Strategic Tool for Navigating the Patient Engagement Solution Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Patient Engagement Solution Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Patient Engagement Solution Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Patient Engagement Solution Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Patient Engagement Solution Market

A detailed market share analysis in the Patient Engagement Solution Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Patient Engagement Solution Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Patient Engagement Solution Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Patient Engagement Solution Market

A strategic analysis of the Patient Engagement Solution Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Patient Engagement Solution Market, highlighting leading vendors and their innovative profiles. These include AdvancedMD, Inc., Allscripts Healthcare, LLC, Athenahealth Inc., Cerner Corporation, Cognizant Corporation, CureMD Healthcare Corporation, Epic Systems Corporation, Getwellnetwork, Inc., Internatonal Business Machines Corporation, Iqvia Inc., Kareo Inc., Lincor Solutions Ltd., Mckesson Corporation, Orion Health Inc., and Vivify Health Inc..

Market Segmentation & Coverage

This research report categorizes the Patient Engagement Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Hardware, Services, and Software.
• Based on Deployment Mode, market is studied across On- Cloud and On-Premise.
• Based on End-User, market is studied across Healthcare Payers, Hospitals & Providers, and Pharmaceutical Companies.
• Based on Application, market is studied across Financial Health Management, Health Management, Home Health Management, and Social & Behavioural Management.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising adoption of mobile health apps
    • 5.1.1.2. Government initiatives to promote the patient-centered care
    • 5.1.1.3. Investments in the healthcare information technology
  • 5.1.2. Restraints
    • 5.1.2.1. Patient's data security threats
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing development of wearable health technology
    • 5.1.3.2. On-going developments in patient information management and identification
    • 5.1.3.3. Rising acceptance of cloud-based models in healthcare
  • 5.1.4. Challenges
    • 5.1.4.1. High solution deployment cost
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Patient Engagement Solution Market, by Component

• 6.1. Introduction
• 6.2. Hardware
• 6.3. Services
• 6.4. Software

7. Patient Engagement Solution Market, by Deployment Mode

• 7.1. Introduction
• 7.2. On- Cloud
• 7.3. On-Premise

8. Patient Engagement Solution Market, by End-User

• 8.1. Introduction
• 8.2. Healthcare Payers
• 8.3. Hospitals & Providers
• 8.4. Pharmaceutical Companies

9. Patient Engagement Solution Market, by Application

• 9.1. Introduction
• 9.2. Financial Health Management
• 9.3. Health Management
• 9.4. Home Health Management
• 9.5. Social & Behavioural Management

10. Americas Patient Engagement Solution Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Patient Engagement Solution Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Patient Engagement Solution Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AdvancedMD, Inc.
• 2. Allscripts Healthcare, LLC
• 3. Athenahealth Inc.
• 4. Cerner Corporation
• 5. Cognizant Corporation
• 6. CureMD Healthcare Corporation
• 7. Epic Systems Corporation
• 8. Getwellnetwork, Inc.
• 9. Internatonal Business Machines Corporation
• 10. Iqvia Inc.
• 11. Kareo Inc.
• 12. Lincor Solutions Ltd.
• 13. Mckesson Corporation
• 14. Orion Health Inc.
• 15. Vivify Health Inc.